Journal profile · Clinical Neurology
Acta Neurologica Belgica
ISSN 0300-9009 · eISSN 2240-2993 · Springer International Publishing · BELGIUM · Quarterly · Founded 2012
Acta Neurologica Belgica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2; hybrid open access; APC about USD 4,090; median 89 days to acceptance (112 articles, last 24 months); community-reported acceptance: easy; 260 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Neurologica Belgica is published by Springer International Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Peripheral Neuropathies and Disorders, Multiple Sclerosis Research Studies and Autoimmune Neurological Disorders and Treatments, together about 19.2% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Acta Neurologica Belgica is the official journal of the following national societies:Belgian Neurological Society Belgian Society for Neuroscience Belgian Society of clinical Neurophysiology Belgian Pediatric Neurology Society Belgian Study Group of Multiple Sclerosis Belgian Stroke Council Belgian Headache Society Belgian Study Group of Neuropathology Acta Neurologica Belgica is a quarterly journal that mainly publishes original clinical neurosciences articles. It also accepts basic neurosciences papers if of interest to the clinician.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Patrick CrasPublisher website
Editorial board by country: none in mainland China; most named Belgium 28, France 3, Germany 1, Switzerland 1, Slovenia 1 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Peripheral Neuropathies and DisordersMedicine7.3%
- Multiple Sclerosis Research StudiesMedicine6.7%
- Autoimmune Neurological Disorders and TreatmentsMedicine5.2%
- Parkinson's Disease Mechanisms and TreatmentsMedicine5.1%
- Epilepsy research and treatmentMedicine5.1%
- Migraine and Headache StudiesMedicine4.8%
- Acute Ischemic Stroke ManagementMedicine4.6%
- Neurological disorders and treatmentsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2LetPub ·
- Impact factor (publisher) 2025
- 2Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.6LetPub ·
- SNIP 2026-06
- 0.93LetPub ·
- h-index
- 31LetPub ·
- h-index
- 51OpenAlex ·
- i10-index
- 746OpenAlex ·
- 2-year mean citedness
- 1.35OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 13.72%LetPub ·
Volume
- Articles per year
- 147LetPub ·
- Downloads per year (publisher) 2025
- 499,500Publisher website ·
Articles by year OpenAlex count · 3,250 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 224 | 27 | 24 |
| 2025 | 260 | 35 | 305 |
| 2024 | 262 | 39 | 681 |
| 2023 | 286 | 67 | 1,066 |
| 2022 | 320 | 89 | 1,767 |
| 2021 | 284 | 70 | 2,225 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
89 daysMedian, submission to acceptance · P25–P75 55 days – 145 days
- Acceptance to online
- median 10 days (112 articles)
- Submission to online
- median 108 days
- Sample
- 112 articles with submission and acceptance dates (558 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,090 / EUR 3,090 / GBP 2,690 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted13, with length limits
- case reportEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- consensus papers and guidelinesConsensus papers and Guidelines are written by experts in the Belgian and international neurological community. They should not exceed 3500 words, not include m…Length not stated
- correspondenceEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- correspondencesCorrespondences can be published if they provide original case reports or facts, particularly concerning the diagnostic process or treatment. The letter should …Length not stated
- editorialEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- editorialsEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- imageThe purpose of this section is to give authors a chance to share illustrative, unusual, or significant images with the readers. The article should present a sho…Length not stated
- letterEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- original articleEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …main text ≤ 3,000 words
- research articleEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- reviewEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …main text ≤ 3,500 words
- review articleEditorials dealing with subjects of general informative interest are written by members of the Partner Societies, Editorial and Advisory Board. They should not …Length not stated
- review articlesReview articles are papers by recognized authorities on special topics of general interest. Unsolicited reviews will also be considered. Reviews should not exce…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- AI use Generative AI Images
LLM use policy Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Acta Neurologica Belgica, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. Back to top
Source ↗Publisher website ·- Plagiarism
Plagiarism screening Model summary
the journal may use software to screen for plagiarism
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- BELGIUM
- Language
- Multi-Language
- Frequency
- Quarterly
- Founded
- 2012
- ISSN
- 0300-9009
- Electronic ISSN
- 2240-2993
- Society / sponsor
- Belgian Neurological Society
- Latest issue on the website
- Volume 126, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Acta Neurologica Belgica
What CAS zone is Acta Neurologica Belgica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Neurologica Belgica is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Neurologica Belgica?
The latest impact factor listed by LetPub is 2; CiteScore 4, h-index 51.
How long does peer review take at Acta Neurologica Belgica?
Based on the dates recorded on 112 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 55–145 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Acta Neurologica Belgica?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Acta Neurologica Belgica based?
Of the 34 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Belgium (28), France (3) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Neurologica Belgica?
According to LetPub and DOAJ records, Acta Neurologica Belgica is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is Acta Neurologica Belgica open access, and what is the APC?
Acta Neurologica Belgica is a hybrid journal. For open-access publication: APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .